These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36675027)

  • 1. Aminoglycoside uptake, stress, and potentiation in Gram-negative bacteria: new therapies with old molecules.
    Lang M; Carvalho A; Baharoglu Z; Mazel D
    Microbiol Mol Biol Rev; 2023 Dec; 87(4):e0003622. PubMed ID: 38047635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining access without excess: expanding appropriate use of antibiotics targeting multidrug-resistant organisms.
    Patel TS; Sati H; Lessa FC; Patel PK; Srinivasan A; Hicks LA; Neuhauser MM; Tong D; van der Heijden M; Alves SC; Getahun H; Park BJ
    Lancet Microbe; 2024 Jan; 5(1):e93-e98. PubMed ID: 37837986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photocatalytic Antimicrobials: Principles, Design Strategies, and Applications.
    Ran B; Ran L; Wang Z; Liao J; Li D; Chen K; Cai W; Hou J; Peng X
    Chem Rev; 2023 Nov; 123(22):12371-12430. PubMed ID: 37615679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining for novel antibiotics in the age of antimicrobial resistance.
    Udaondo Z; Matilla MA
    Microb Biotechnol; 2020 Nov; 13(6):1702-1704. PubMed ID: 32881368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridyl-Linked Hetero Hydrazones: Transmembrane H
    Mondal A; Siwach M; Ahmad M; Radhakrishnan SK; Talukdar P
    ACS Infect Dis; 2024 Feb; 10(2):371-376. PubMed ID: 38262044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of infections caused by multi-resistant microorganisms in hospital at home units.
    Mirón-Rubio M
    Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):18-21. PubMed ID: 34598417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review.
    Hashempour-Baltork F; Hosseini H; Shojaee-Aliabadi S; Torbati M; Alizadeh AM; Alizadeh M
    Adv Pharm Bull; 2019 Aug; 9(3):335-347. PubMed ID: 31592430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New candidate to combat drug-resistant bacteria.
    Bagcchi S
    Lancet Infect Dis; 2024 Apr; 24(4):e227. PubMed ID: 38521076
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of genes related to the efflux pump and porin in multidrug-resistant Escherichia coli strains isolated from patients with COVID-19 after secondary infection.
    Ganjo AR; Balaky STJ; Mawlood AH; Smail SB; Shabila NP
    BMC Microbiol; 2024 Apr; 24(1):122. PubMed ID: 38600509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma-A Narrative Review.
    Luo Y; Sun M; Tan L; Li T; Min L
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latest Review Papers in Molecular Microbiology.
    Burkovski A
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring Antibiotic-Potentiating Effects of Tobramycin-Deferiprone Conjugates in
    Gandhi K; Dhiman S; Arora R; Ramirez DM; Ramirez D; Arthur G; Schweizer F
    Antibiotics (Basel); 2023 Jul; 12(8):. PubMed ID: 37627681
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Dofini Magnini R; Pedinielli F; Vergalli J; Ouedraogo N; Remy S; Hilou A; Brunel JM; Pagès JM; Davin-Regli A
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rejuvenating the Activity of Usual Antibiotics on Resistant Gram-Negative Bacteria: Recent Issues and Perspectives.
    Tabcheh J; Vergalli J; Davin-Régli A; Ghanem N; Pages JM; Al-Bayssari C; Brunel JM
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
    Liu Y; Li R; Xiao X; Wang Z
    Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-Resistant Gram-Negative Bacteria and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae from the Poultry Farm Environment.
    Veloo Y; Thahir SSA; Rajendiran S; Hock LK; Ahmad N; Muthu V; Shaharudin R
    Microbiol Spectr; 2022 Jun; 10(3):e0269421. PubMed ID: 35467407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids.
    Gupta V; Datta P
    Indian J Med Res; 2019 Feb; 149(2):97-106. PubMed ID: 31219074
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.